IRWD

NASDAQStock

Ironwood Pharmaceuticals, Inc.

$3.39-0.29 (-8.02%)

52-Week Range

$0.57
$5.39

Key Stats

Market Cap

552.8M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.19

Volume

1.1M

Avg Volume

3.7M

Performance

1M

-23.87%

3M

-5.85%

6M

+164.06%

YTD

-20.84%

1Y

+123.84%

3Y

-68.47%

5Y

-69.62%

Price Chart

ETF Exposure

IRWD is held by 66 ETFs

ETFFund NameWeight
DFACDimensional - US Core Equity 2 ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About IRWD ETF Exposure

Ironwood Pharmaceuticals, Inc. (IRWD) is held by 66 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 552.8M, IRWD is a widely held institutional stock. The stock currently trades at $3.39. Investors can gain exposure to IRWD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IRWD, sorted by portfolio weight.